220
Participants
Start Date
October 11, 2021
Primary Completion Date
October 31, 2026
Study Completion Date
November 30, 2026
Benralizumab Prefilled Syringe
Patients receive BENRALIZUMAB if they meet the criteria for inclusion and non-inclusion at the inclusion visit. Injections take place at the inclusion visit, at 1 month, 2 months, 4 months, 6 months, 8 months, 10 months and 12 months.
RECRUITING
Centre hospitalier Intercommunal Aix-en-Provence, Aix-en-Provence
RECRUITING
CHU Angers, Angers
RECRUITING
CHU Bordeaux, Bordeaux
RECRUITING
CHRU Brest, Brest
RECRUITING
CHU Dijon, Dijon
RECRUITING
CHU Grenoble, Grenoble
RECRUITING
Hôpital Bicêtre - AP-HP, Le Kremlin-Bicêtre
WITHDRAWN
CH Mans, Le Mans
WITHDRAWN
CHU Lille, Lille
RECRUITING
Hospices Civils de Lyon, Lyon
NOT_YET_RECRUITING
Assistance Publique des Hôpitaux de Marseille, Marseille
WITHDRAWN
CHU Montpellier, Montpellier
RECRUITING
CHU Nantes, Nantes
RECRUITING
CHR Orléans, Orléans
RECRUITING
Hôpital Bichat - AP-HP, Paris
WITHDRAWN
CHU Rouen, Rouen
RECRUITING
CHU Strasbourg, Strasbourg
RECRUITING
Hôpital FOCH, Suresnes
RECRUITING
CHU Toulouse, Toulouse
RECRUITING
Médipôle Hôpital Mutualiste de Villeurbanne, Villeurbanne
Collaborators (1)
AstraZeneca
INDUSTRY
Ministère de la Santé - France
UNKNOWN
Nantes University Hospital
OTHER